Objective-Adipose tissue cholesterol increases with adipocyte triglyceride content and size during development of obesity. However, how adipocyte cholesterol affects adipocyte function is poorly understood. The aim of this study was to evaluate the role of the cellular cholesterol exporter, Abca1 (ATP-binding cassette transporter A1), on adipose tissue function during diet-induced obesity. Approach and Results-Adiponectin Cre recombinase transgenic mice were crossed with Abca1 flox/flox mice to generate ASKO (adipocyte-specific Abca1 knockout) mice. Control and ASKO mice were then fed a high-fat, high-cholesterol (45% calories as fat and 0.2% cholesterol) diet for 16 weeks. Compared with control mice, ASKO mice had a 2-fold increase in adipocyte plasma membrane cholesterol content and significantly lower body weight, epididymal fat pad weight, and adipocyte size. ASKO versus control adipose tissue had decreased PPARγ (peroxisome proliferator-activated receptor γ) and CCAAT/ enhancer-binding protein expression, nuclear SREBP1 (sterol regulatory element-binding protein 1) protein, lipogenesis, and triglyceride accretion but similar Akt activation after acute insulin stimulation. Acute siRNA-mediated Abca1 silencing during 3T3L1 adipocyte differentiation reduced adipocyte Abca1 and PPARγ protein expression and triglyceride content. Systemic stimulated triglyceride lipolysis and glucose homeostasis were similar between control and ASKO mice. transporter A1) from adipocytes. Abca1 is a membrane protein that exports cellular cholesterol and phospholipids to apolipoproteins, generating nascent high-density lipoprotein (HDL) particles. 24 Abca1 is highly expressed in adipose tissue, 25 and its expression is important in mobilizing adipose tissue cholesterol for transport to the liver for excretion. 22, 26 Previous studies suggest that adipocyte Abca1 contributes significantly to plasma cholesterol concentrations and is the major cholesterol efflux mechanism in adipocytes. 22, 23 However, the model used (ie, aP2 Cre recombinase mouse) also results in partial and variable myeloid cell (ie, macrophage, monocyte, and neutrophil) Abca1 deletion. 22, 27 Myeloid-specific Abca1 gene deletion results in proinflammatory macrophages that are functionally distinct from macrophages expressing Abca1. [28] [29] [30] This is an important point because macrophages are the primary source of inflammatory cytokine expression in adipose tissue, 31 and cytokines contribute to development of insulin resistance.
O besity continues to increase at an alarming rate in the US population, with 67% of adults classified as overweight or obese based on body mass index. 1, 2 Obesity is a risk factor for other chronic diseases and is associated with increased prevalence of type 2 diabetes mellitus, hypertension, dyslipidemia, and cardiovascular disease. 2, 3 With the onset of obesity, adipocytes increase in size because of increased triglyceride accumulation, which protects against lipotoxicity in other organs because excess circulating fatty acids are esterified into triglyceride and stored in adipocytes. However, if fatty acid flux into adipose tissue exceeds the ability of adipocytes to store the excess energy as triglyceride, adipocyte dysfunction and ultimately cell death occurs. Large dysfunctional adipocytes are characterized by decreased responsiveness to insulin, 4, 5 decreased glucose uptake, increased endoplasmic reticulum and mitochondrial stress, 6 reactive oxygen species, 7, 8 and proinflammatory cytokine secretion. [9] [10] [11] However, obesity and adipocyte hypertrophy do not lead to adipose tissue dysfunction in all cases, [12] [13] [14] suggesting that additional factors contributing to adipose tissue dysfunction remain to be identified.
See accompanying editorial on page 687
Cholesterol and triglyceride accumulate proportionally in adipocytes during weight gain. 15 Although much research has focused on adipocyte triglyceride accumulation, little is known about how cholesterol accumulation affects adipocyte function. Unlike other tissues, adipocytes store nearly all cholesterol as free cholesterol (FC; >93% of total cholesterol). In obesity, adipocytes can contain ≤50% of the body's FC, making it the largest FC pool. 16 Adipocytes also exhibit low levels of cholesterol synthesis compared with other tissues, suggesting that most adipocyte cholesterol comes from dietary sources. 17, 18 Several studies suggest a link between cholesterol content and adipose tissue inflammation 19, 20 and insulin resistance 21 ; however, how adipocyte cholesterol content influences adipose tissue inflammation and insulin resistance is poorly understood.
To determine how cholesterol accumulation affects adipocyte function, our laboratory 22 and others' 23 have used in vivo mouse models to delete the Abca1 (ATP-binding cassette transporter A1) from adipocytes. Abca1 is a membrane protein that exports cellular cholesterol and phospholipids to apolipoproteins, generating nascent high-density lipoprotein (HDL) particles. 24 Abca1 is highly expressed in adipose tissue, 25 and its expression is important in mobilizing adipose tissue cholesterol for transport to the liver for excretion. 22, 26 Previous studies suggest that adipocyte Abca1 contributes significantly to plasma cholesterol concentrations and is the major cholesterol efflux mechanism in adipocytes. 22, 23 However, the model used (ie, aP2 Cre recombinase mouse) also results in partial and variable myeloid cell (ie, macrophage, monocyte, and neutrophil) Abca1 deletion. 22, 27 Myeloid-specific Abca1 gene deletion results in proinflammatory macrophages that are functionally distinct from macrophages expressing Abca1. [28] [29] [30] This is an important point because macrophages are the primary source of inflammatory cytokine expression in adipose tissue, 31 and cytokines contribute to development of insulin resistance.
To address this issue, we generated an ASKO (adipocytespecific Abca1 knockout) mouse model using an adiponectin Cre recombinase mouse, so that macrophage Abca1 expression remained intact. 27 This model allowed us to study the impact of Abca1 expression and adipocyte cholesterol accumulation on adipocyte function. Our results demonstrate that adipocyte Abca1 is critical for regulating adipose tissue cholesterol content and that genetic deletion of adipocyte Abca1 expression results in mice that are resistant to diet-induced obesity.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Abca1 Is Selectively Deleted From Adipose Tissue
Previous reports on in vivo adipocyte Abca1 deletion used an Abca1 flox/flox mouse crossed with an aP2 Cre recombinase mouse 22, 23 ; however, the resulting knockout mice also demonstrated partial and variable myeloid Abca1 deletion, complicating interpretation of results. In this study, we created an ASKO mouse model by crossing Figure 1A ). In contrast, no apparent decrease in Abca1 protein expression was observed in macrophages (peritoneal or bone marrow-derived) or liver, demonstrating selectivity for elimination of adipocyte Abca1. Abca1 gene expression was significantly reduced in adipose tissue but not in liver ( Figure 1B) . Although other Abca1-expressing tissues were not examined, previous work has shown adipocyte specificity with the adiponectin Cre recombinase mouse. 27, 32 Adipocyte Abca1 Deletion Significantly Reduces Plasma HDL Concentration
The previous adipocyte Abca1 knockout mouse model (made with an aP2 Cre recombinase mouse) had a slight but significant decrease in total plasma cholesterol and HDL cholesterol in 2 separate studies. 22, 23 In our study, total plasma, LDL (low-density lipoprotein), and HDL cholesterol concentrations were measured in mice before (chow) and after 16 weeks of consuming a high-fat, high-cholesterol (HFHC) diet. ASKO mice had significantly reduced (≈30%) total plasma cholesterol ( Figure 1C ; genotype, P<0.015) and HDL cholesterol ( Figure 1D ; genotype, P<0.028) concentrations compared with control mice. However, because few age-matched, chow-fed mice were analyzed, post hoc analyses did not show a significant difference for total plasma cholesterol and HDL cholesterol between chow-fed control and ASKO mice. No differences were observed in plasma concentrations of LDL, VLDL (data not shown), or triglyceride between the 2 genotypes ( Figure 1E and 1F).
ASKO Mice Are Resistant to DietInduced Weight Gain
To determine the systemic effects of adipocyte-specific Abca1 gene deletion, mice were fed an HFHC diet for 16 weeks starting at 8 weeks of age. A smaller cohort was maintained on chow from weaning until 24 weeks of age. ) were used because their phenotypes (body and fat pad weight, plasma cholesterol, adipocyte size, and adipose cholesterol content) were indistinguishable from Abca1 +/+ mice. Both genotypes gained weight at a similar rate while consuming a chow diet. Strikingly, ASKO mice failed to gain weight on the HFHC diet compared with their control counterparts ( Figure 2A ). In fact, weight gain for HFHC dietfed ASKO mice was similar to chow-fed mice, resulting in terminal body weights significantly lower in HFHC-fed ASKO than in HFHC-fed control mice (32.0±1.4 versus 39.9±1.1 g; P<0.0017; Figure 2B ). These results demonstrate that adipocyte-specific Abca1 deletion confers resistance to HFHC dietinduced obesity.
Similar patterns were observed in white adipose tissue weight. On an HFHC diet, control mice had 2-fold higher epididymal white adipose tissue (EAT) mass compared with ASKO mice (1.99±0.14 versus 1.12±0.12 g, respectively; P<0.0001), whereas EAT mass was similar for chow-fed control and ASKO mice (0.48±0.10 versus 0.55±0.09 g, respectively;
Nonstandard Abbreviations and Acronyms Figure 2C ). HFHC diet-fed ASKO mice had larger EAT mass than their chow-fed counterparts (P=0.02), despite having no difference in body weight; however, the difference in fat pad weight between chow and HFHC diet-fed ASKO mice (0.57 g) was much smaller than that for control mice (1.51 g). These differences were unaltered when EAT weight was normalized to body weight (data not shown). Liver:body weight ratio was similar for all mice (data not shown). To measure body fat composition, the total amount of fat in EAT, subcutaneous adipose tissue, BAT, and retrorenal depots was measured and normalized to body weight. HFHC diet-fed ASKO mice had a lower percentage of body weight as fat compared with control mice (11.4±0.9% versus 8.8±0.8%; P=0.04; Figure 2D ). Snout-to-tail length, measured at necropsy, was similar for both genotypes, supporting no growth retardation in ASKO mice ( Figure 2E ). Together, these data show that ASKO mice are resistant to HFHC diet-induced weight gain.
Abca1 Deletion Results in Smaller Adipocytes
Adipocyte hypertrophy is believed to be the major mechanism for adipose tissue expansion during weight gain, and hypertrophied adipocytes are associated with metabolic dysfunction. 34 We determined whether adipocyte Abca1 deletion alters adipocyte size. Adipose tissue sections from ASKO and control mice fed HFHC and chow diets were stained with hematoxylin and eosin and examined microscopically. ASKO EAT adipocytes from HFHC diet-fed 
Adipocyte-Specific Abca1 Deletion Has Minimal Impact on Metabolic Phenotype
Because ASKO mice gained less weight on the HFHC diet compared with control mice, we subjected both genotypes to metabolic phenotyping. Mice fed the HFHC diet for 16 weeks were placed in metabolic cages (CLAMS [Comprehensive Lab Animal-Monitoring System]) for 4 days: 2 days for acclimation and 2 days for measurements. Although ASKO mice had significantly (P<0.05) increased oxygen consumption, carbon dioxide production, and heat production during the dark cycle when the data were normalized for body weight (data not shown), this was not the case when the data were expressed on a per mouse basis ( Figure IIA through IIC in the online-only Data Supplement), as suggested in recent literature. 35, 36 Analysis of covariance of body weight versus heat production 35 showed no significant genotype difference between ASKO and control mice (data not shown). Physical activity ( Figure IID 
ASKO Mice Have Higher Adipose Tissue Cholesterol Content
We next examined the impact of adipocyte Abca1 deletion on adipose tissue cholesterol content. EAT from ASKO mice had ≈3-fold higher levels of cholesterol compared with control mice, regardless of diet ( Figure 3A) . However, EAT stromal vascular cells from both genotypes had similar cholesterol content (7.2±1.1 and 6.4±1.1 µg/mg protein, respectively, n=4 per genotype), demonstrating that adipocyte Abca1 deletion had minimal effect on stromal vascular cell cholesterol content. ABCG1 (ATPbinding cassette transporter G1) gene expression increased, and cholesterol synthesis (HMGCoA [3-hydroxy-3-methyl-glutarylcoenzyme A] synthase) and lipoprotein receptor gene (LDLr [low-density lipoprotein receptor] and VLDLr [very-low-density lipoprotein receptor]) expression decreased significantly in response to deletion of adipocyte Abca1, in ASKO versus control mice fed the HFHC diet ( Figure 3B ). Gene expression results were confirmed for ABCG1 and LDLr protein expression by Western blot analysis ( Figure 3C and 3D) . Previously, we demonstrated that increased plasma membrane FC and lipid raft content resulted in augmented macrophage inflammatory signaling in macrophage-specific Abca1 knockout mice. 28, 29 We isolated adipocyte plasma membranes and observed a 2-fold increase in cholesterol content for ASKO versus control mice ( Figure 3E ). Lipid rafts were also visualized using fluorescent-labeled β-cholera toxin on adipose tissue sections; ASKO adipose tissue Male Cntl (control) and ASKO (adipocyte-specific Abca1 knockout) mice were fed chow for 24 wk (n=5-6) or a high-fat, high-cholesterol (HFHC) diet for 16 wk starting at 8 wk of age (n=20). Mice were euthanized at 24 wk of age to harvest adipose tissue. A, Body weight gain during dietary feeding. B, Terminal body weights. C, Epididymal white adipose tissue (EAT) weight harvested at 24 wk of age. D, Percentage of body weight as fat was calculated by summing the weight of epididymal, retrorenal, subcutaneous, and brown fat depots and dividing the sum by total body weight×100% for each mouse. E, Snout-totail length of mice at 24 wk of age. F, Representative photomicrographs of EAT harvested at 24 wk of age. G, Histogram of EAT adipocyte cross-sectional area; 300 cell measurements per mouse were taken from n=6 mice per genotype. demonstrated increased lipid raft staining ( Figure 3F ). These data demonstrate a remarkable increase in adipocyte cholesterol in the absence of Abca1 that cannot be overcome by the usual compensatory cellular responses to increased cellular cholesterol.
ASKO Mice Have Reduced Adipose Tissue Triglyceride
Previous studies have shown that the adipocyte cholesterolto-triglyceride ratio remains relatively constant regardless of adipocyte size. 17 Given the smaller adipocyte phenotype along with increased adipose cholesterol in ASKO mice, we next examined whether adipose triglyceride metabolism was affected. As anticipated, EAT from HFHC diet-fed ASKO mice contained less triglyceride than EAT from control mice ( Figure 4A ). There are several reasons why triglyceride may be lower in ASKO adipocytes. We first explored whether ASKO adipocytes were more lipolytic compared with control adipocytes. After 8 weeks of HFHC diet feeding, control and ASKO mice were stimulated with a β3-specific adrenergic receptor agonist to induce lipolysis. There was no significant difference in plasma nonesterified free fatty acid levels before and after β3-agonist stimulation between ASKO and control mice, indicating that deletion of adipocyte Abca1 does not alter in vivo lipolytic potential ( Figure 4B ). We next examined [ 
Adipocyte Abca1 Deletion Does Not Affect Adipose Tissue Insulin Sensitivity
Because HFHC diet-fed ASKO mice had smaller adipocytes that contained less triglyceride and synthesized less triglyceride relative to control adipocytes, we hypothesized that insulin signaling might also be attenuated in ASKO adipose tissue. Fasting blood glucose concentrations were similar in ASKO and control mice, regardless of diet ( Figure 5A ). Plasma insulin concentrations were similar between genotypes in chow-fed mice but significantly higher in HFHC diet-fed ASKO versus control mice ( Figure 5B ). Insulin signaling was examined in EAT, liver, and skeletal muscle collected 5 minutes after portal vein insulin injection. Contrary to our hypothesis, insulin signaling, measured as Akt phosphorylation, was similar between genotypes in all 3 tissues ( Figure 5C and 5D ). To examine systemic glucose homeostasis, glucose and insulin tolerance tests were performed on mice fed chow until 24 weeks of age or the HFHC diet for 16 weeks, starting at 8 weeks of age. Although HFHC diet-fed mice were defective in plasma glucose disposal compared with chow-fed counterparts, glucose tolerance ( Figure 5E ) and insulin tolerance ( Figure 5F ) curves were indistinguishable between genotypes, suggesting that deletion of adipocyte Abca1 did not affect systemic insulin resistance.
EAT Lipid Accretion Pathways Are Downregulated in ASKO Mice
Because insulin signaling could not explain reduced adipocyte triglyceride content and lipogenesis in ASKO mice, we further examined lipid accretion pathways. PPARγ (peroxisome proliferator-activated receptor γ) and C/EBP1 (CCAAT/ enhancer-binding protein) α and β gene expression were significantly decreased in EAT of HFHC-fed ASKO mice ( Figure 6A ). These genes are the major transcription factors that govern triglyceride accumulation during adipocyte differentiation. 37 Other genes involved in adipocyte triglyceride synthesis, such as DGAT (acyl-CoA:diacylglycerol acyltransferase) 1 and 2, or lipid uptake (ie, CD36) were also decreased in ASKO EAT. These data were confirmed by Western blot analysis of PPARγ, SCD-1 (stearoyl-CoA desaturase 1), and CD36 ( Figure 6B and 6C) .
SREBP1c (sterol regulatory element-binding protein 1c) is a major regulatory pathway responsible for the promotion of de novo lipogenesis and triglyceride storage. 38 Accordingly, we examined nuclear (ie, activated) SREBP1c levels in adipocytes isolated from EAT of mice fed a HFHC diet for 16 weeks; nuclear SREBP1 protein was decreased in ASKO versus control adipocytes ( Figure 6D ). To determine whether transient loss of adipocyte Abca1 protein expression impaired adipocyte differentiation by decreasing PPARγ expression, we silenced Abca1 in 3T3L1 cells during differentiation into adipocytes and examined PPARγ and aP2 protein expression. Abca1 protein expression was strikingly reduced in 3T3L1 adipocytes by day 2 of Abca1 siRNA treatment compared with control-treated cells ( Figure 6E ) and began to increase during days 6 to 8. Reduction of Abca1 protein was associated with decreasing expression of PPARγ and aP2-a target of PPARγ-( Figure 6E ) and reduced adipocyte triglyceride content ( Figure 6F ). Based on these results, we proposed that deletion of Abca1 resulted in decreased expression and activation of PPARγ, which in turn leads to decreased lipid accretion and smaller adipocytes.
Deletion of Abca1 in BAT Has Minimal Effect on BAT Function
BAT weight did not differ between control and ASKO animals ( Figure IIIA 
Deletion of Abca1 in Adipose Tissue Does Not Increase Adipose Tissue Inflammation
In previous studies, increased adipose tissue cholesterol content driven by dietary cholesterol intake was associated with increased adipose tissue inflammation. 19, 39 Despite a 3-fold increase in EAT cholesterol ( Figure 3A ), proinflammatory and endoplasmic reticulum stress-related gene expression did not increase in EAT of ASKO relative to control mice, although inflammatory gene expression did increase in mice fed the HFHC diet versus the chow diet ( Figure IVA in the online-only Data Supplement). CD68 immunofluorescence was similar for ASKO and control adipose tissue ( Figure IVB in the online-only Data Supplement), in agreement with the gene expression data. Previous studies have shown a direct correlation between dietary cholesterol, adipose tissue cholesterol, and inflammation 39, 40 ; however, this is not the case in our ASKO model, likely because of selective increases in cholesterol in adipocytes but not stromal vascular cells.
Discussion
This study was designed to elucidate the role of adipocyte Abca1 expression on adipocyte lipid homeostasis. Previous studies have shown that Abca1 is abundantly expressed in Figure 5 . Male Cntl (control) and ASKO (adipocyte-specific Abca1 knockout) mice were fed chow for 24 wk or a high-fat, high-cholesterol (HFHC) diet for 16 wk starting at 8 wk of age and then fasted for 12 h before blood and plasma were collected for glucose (A) and insulin (B) measurements, respectively. C, Male mice fed an HFHC diet for 16 wk were fasted overnight, anesthetized, and injected with insulin (1 U/kg) in the portal vein. Five minutes later, mice were euthanized and epididymal white adipose tissue (EAT), liver, and skeletal muscle were harvested for Western blot analysis of p-Akt and total Akt expression. D, Western blot quantification of p-Akt/total Akt from blots in C. E, Glucose tolerance tests were performed on mice fed the HFHC diet for 16 wk after a 12-h fast. F, Insulin tolerance tests were performed on mice fed the HFHC diet for 16 wk after a 12-h fast. Different letters (A and B) denote statistical difference by ANOVA and Tukey multiple comparisons test, P<0.05. adipose tissue 22 ; however, its role in adipocyte lipid homeostasis and function in vivo is poorly understood. Previous studies using aP2 Cre recombinase-mediated deletion of Abca1 flox/flox alleles were complicated by concomitant and variable Abca1 gene deletion in macrophages in addition to adipocytes. 22, 23 In the present study, we generated a mouse model with adipocyte-specific deletion of the Abca1 gene using adiponectin Cre recombinase-mediated deletion, allowing us to more clearly detect the effects of Abca1 expression in adipocytes.
ASKO mice had significantly lower total plasma and HDL cholesterol concentrations compared with control mice (Figure 1C and 1D ). This agrees with our previous findings 22 that adipose Abca1 contributes minimally (<15%) to total plasma cholesterol levels in vivo, which are primarily determined by Abca1 expression in the liver 41 and small intestine. 42 Despite marginal impact on plasma cholesterol concentrations, adipocyte Abca1 deletion resulted in significantly higher levels of adipose tissue cholesterol content. We observed a 3-fold increase in total cholesterol in both white adipose tissue and BAT ( Figure 3A ; Figure IIIB in the onlineonly Data Supplement), despite the fact that ABCG1 was upregulated and cholesterol synthesis and uptake genes were downregulated in ASKO adipose tissue ( Figure 3B ). These results strongly suggest that Abca1 is the major cholesterol efflux system in adipocytes and that in its absence, other pathways of cellular cholesterol homeostasis cannot compensate. These results are in contrast to those of early in vitro experiments, which reported that Abca1 only effluxes cholesterol under conditions of prolonged lipolysis. 43 On the contrary, our findings agree with those in other in vivo models that examined adipose Abca1 expression in vivo. 22, 23 Adipocyte cholesterol balance may play a significant role in determining adipocyte size and triglyceride content, particularly during progression of obesity. 21, 44, 45 For example, adipocyte cholesterol accumulation is associated with triglyceride accretion during adipocyte hypertrophy. 15 However, in our study, ASKO mice had a 3-fold increase in adipose tissue cholesterol but reduced adipose tissue triglyceride content and adipocyte size (Figures 2G and 4A) . The reason for the difference in outcomes between our study and previous ones may be attributed to the high levels of plasma membrane cholesterol in ASKO adipocytes ( Figure 3E ). Adipocyte cholesterol moves from the plasma membrane to the lipid droplet during hypertrophy, leading to enlarged adipocytes and relative depletion of plasma membrane cholesterol. 21 Adipocytes seem to sense cholesterol redistribution from the plasma membrane to lipid droplets as a form of cellular cholesterol depletion. 21, 43, 44, 46 Supporting this notion, hypertrophied adipocytes activate SREBP2 and upregulate cholesterol synthesis genes, despite higher levels of cellular cholesterol. 21 In the absence of adipocyte Abca1, cholesterol redistribution from the plasma membrane to lipid droplets may be compromised.
To determine why ASKO mice had lower fat pad weight and smaller adipocytes, we examined adipose tissue triglyceride metabolism. We determined that β3 adrenergic-stimulated triglyceride lipolysis in vivo was similar between genotypes ( Figure 4B ). In contrast, ASKO EAT was less able to incorporate radiolabeled oleic acid and acetate into triglyceride ( Figure 4C and 4D), and expression of major lipogenic genes and transcription factors (ie, PPARγ, C/EBPs, and SREBP1c) was downregulated in the adipose tissues of ASKO mice compared with their control counterparts ( Figure 6A and 6B) . The most likely explanation for our findings is that accumulation of cholesterol without adipocyte Abca1 expression inhibited SREBP1c processing by increasing endoplasmic reticulum cholesterol content, 47 diminishing de novo lipogenesis and PPARγ expression, which is a direct transcriptional target of SREBP1c. 48 Reduced lipogenesis and fatty acid uptake would decrease potential ligands for PPARγ activation and substrate for triglyceride synthesis. 49 Interestingly, despite a 3-fold increase in EAT cholesterol content in ASKO mice, we observed only minor effects on adipose tissue inflammation ( Figure IVA and IVB in the online-only Data Supplement). Previous work has shown that addition of dietary cholesterol alone can lead to adipose inflammation. 19, 39 Several studies, including our own, have demonstrated that dietary cholesterol leads to increased adipose tissue cholesterol content, macrophage infiltration, and inflammation. 39, 40, 50 These studies show a ≈50% increase in adipose cholesterol content as a result of increased dietary cholesterol intake. In contrast, ASKO mice had a ≈300% increase in EAT cholesterol, suggesting that adipocyte cholesterol content alone does not determine adipose tissue inflammation and that macrophages, not adipocytes, are primarily responsible for dietary cholesterol-induced inflammation. The absence of increased EAT inflammation in HFHC diet-fed ASKO versus control mice may also explain why systemic insulin resistance was similar between genotypes.
Macrophage infiltration into adipose tissue is likely the main contributor to adipose tissue inflammation that accompanies weight gain and obesity. 6, 19, [51] [52] [53] [54] We also showed that a small increase in macrophage membrane FC and lipid raft content induced by macrophage-specific Abca1 deletion results in an exaggerated proinflammatory response to TLR4 (Tolllike 4 receptor) agonists (ie, lipopolysaccharide), 29 supporting the idea that increased adipose tissue macrophage cholesterol may result in increased adipose tissue inflammation. However, increased macrophage inflammation per se does not result in the systemic insulin resistance that accompanies obesity, 55 suggesting that adipose tissue macrophage inflammation and adipocyte dysfunction are both necessary to display the full metabolic phenotype in obese states.
ASKO mice consuming an HFHC diet had significantly less weight gain compared with control mice. One explanation for this outcome may be related to higher energy expenditure by ASKO mice during the dark cycle ( Figure II in the onlineonly Data Supplement). However, when energy expenditure data were not normalized to body weight, there was no difference between genotypes. Although the most appropriate way to report metabolic data has been debated, 36 most studies normalize energy expenditure to body weight as we did. Different energy expenditures could not be explained by differences in BAT mass or UCP1 (uncoupling protein 1) expression. We also found no consistent evidence for beiging or browning of white adipose tissue (subcutaneous and visceral) based on UCP1 gene and protein expression (data not shown). However, in an acute cold tolerance experiment, ASKO mice had a slight, but significant, elevation of body temperature compared with control mice, in agreement with the increased energy expenditure data.
We also observed similar food intake and activity between control and ASKO mice. However, a small decrease in food intake in ASKO mice may not have been detected over the relatively short food intake experiments. For example, an 8-g difference in body weight between control and ASKO mice during a 16-week feeding period is an average body weight gain of 0.071 g/d (8 g per 112 days); detecting a difference in food consumption needed to produce this small change in body weight during a 2-day (CLAMS experiment) or 1-week (manual food intake experiment) observational period may be difficult ( Figure IIF in the online-only Data Supplement). More detailed studies will be necessary to understand the mechanisms for lower body weights in HFHC diet-fed ASKO mice.
The results of our study may have clinical implications. During development of obesity, as adipocyte size and triglyceride content increases, adipocyte cholesterol also increases, reaching 50% of the total body cholesterol pool in extreme cases of obesity. 15 Cellular cholesterol accumulation normally would increase expression of ABCA1 and other cholesterol export proteins through activation of the transcription factor LXR (liver X receptor). We have shown increased visceral fat expression of ABCA1 and apolipoprotein E, 2 LXR target genes, in nonhuman primates fed increased dietary cholesterol, which may provide protection from adipocyte cholesterol overload. 39 Obesity is also accompanied by increased adipose tissue and systemic inflammation, and we and others have shown that inflammatory stimuli downregulate ABCA1 expression. 30, 56 Based on results from the present study, this may afford adipocytes a protective mechanism to avoid excessive triglyceride accumulation, which may lead to adipocyte death, by downregulating triglyceride synthesis as adipocyte FC accumulates.
In summary, the results from our mouse model provide additional mechanistic insights into cholesterol metabolism in adipose tissue. Surprisingly, deletion of Abca1 in adipocytes was mostly beneficial, resulting in lower weight gain, reduced body fat, and increased energy expenditure, with no alteration in systemic glucose and insulin sensitivity or adipose tissue inflammation. We posit that most of these results are because of the high level of membrane cholesterol in ASKO adipocytes. By preventing cholesterol efflux through Abca1, we artificially raised membrane cholesterol levels and prevented the adipocyte hypertrophy normally observed in HFHC dietfed mice. Our results demonstrate an important role for adipocyte Abca1 in the regulation of adipocyte function.
